abbrevi
use
spike
sarscov
sever
acut
respiratori
syndrom
coronaviru
mlv
murin
leukemia
viru
dcsign
dendrit
cellspecif
intercellular
adhes
nonintegrin
argiotensin
consert
enzym
figur
introduct
alanin
residu
region
modul
elastaseinduc
viru
entri
mediat
sarscov
b
pseudotyp
virion
infect
perform
describ
fig
infect
induc
treatment
elastas
trypsin
b
result
present
rel
light
unit
rlu
error
bar
repres
se
three
independ
experi
c
cleavag
sarscov
elastas
cell
express
wild
type
wt
mutant
sarscov
spike
protein
treat
gml
elastas
cell
surfac
protein
biotinyl
precipit
cleavag
product
sarscov
spike
protein
analyz
western
blot
antibodi
recogn
tag
c
terminu
protein
proteolyt
prime
common
method
control
activ
membran
fusion
mediat
viral
glycoprotein
sever
acut
respiratori
syndrom
coronaviru
spike
protein
sarscov
prime
varieti
host
cell
proteas
proteolyt
cleavag
occur
boundari
adjac
fusion
peptid
domain
studi
prime
sarscov
elastas
show
import
role
residu
thr
domain
seri
alanin
mutant
gener
vicin
cleavag
site
goal
examin
elastasemedi
cleavag
within
proteolyt
cleavag
fusion
activ
modul
alter
cleavag
site
posit
propos
novel
mechan
wherebi
sarscov
fusion
protein
function
control
spatial
regul
proteolyt
prime
site
import
implic
viral
pathogenesi
spike
protein
sever
acut
respiratori
syndrom
coronaviru
sarscov
class
viral
fusion
protein
respons
receptor
bind
membran
fusion
viral
entri
like
class
fusion
protein
sarscov
protein
undergo
proteolyt
prime
prior
fusion
activ
sever
host
cell
proteas
appear
abl
prime
fusion
activ
case
sarscov
includ
cathepsin
l
trypsin
factor
xa
thermolysin
plasmin
elastas
proteolyt
cleavag
event
sarscov
lead
membran
fusion
occur
interfac
receptor
bind
fusion
domain
well
adjac
fusion
peptid
within
elastasemedi
activ
sarscov
origin
report
taguchi
cowork
propos
elastas
may
import
implic
viral
pathogenesi
elastas
known
secret
neutrophil
part
inflammatori
respons
viral
infect
also
produc
opportunist
bacteria
eg
pseudomona
aeruginosa
colon
viral
infect
respiratori
tissu
consid
elastasemedi
activ
sarscov
might
import
factor
sever
pneumonia
seen
sarscovinfect
patient
perform
mutagenesi
studi
sarscov
protein
vicin
fusion
peptideproxim
posit
arg
show
elastas
mediat
fusion
activ
via
residu
thr
wild
type
protein
shift
posit
cleavag
site
rel
fusion
peptid
affect
degre
fusion
activ
modul
viru
infect
cell
cultur
plasmidsvero
cell
hek
cell
american
type
cultur
collect
maintain
dulbecco
modifi
eagl
medium
cellgro
contain
fetal
bovin
serum
unitsml
penicillin
gml
streptomycin
vector
express
sarscov
spike
protein
provid
dr
michael
farzan
new
england
primat
research
center
sitedirect
mutagenesi
carri
via
pcr
use
primer
obtain
idt
technolog
mutat
confirm
sequenc
use
appli
biosystem
autom
dna
analyz
cornel
univers
life
scienc
core
laboratori
center
plasmid
express
luciferas
gene
control
promot
plasmid
express
polymeras
use
quantit
cellcel
fusion
assay
provid
dr
tom
gallagh
loyola
univers
chicago
il
pseudotyp
virion
product
use
gagpol
murin
leukemia
viru
mlv
packag
construct
contain
mlv
gag
pol
gene
mlvluc
plasmid
encod
mlvbase
transfer
vector
contain
cmvluc
intern
transcript
unit
plasmid
provid
dr
jean
dubuisson
institut
de
biologi
de
lill
franc
porcin
pancrea
obtain
sigmaaldrich
tosylphenylalanyl
chloromethyl
ketonetr
trypsin
bovin
pancrea
obtain
pierc
cellcel
fusion
assayhek
cell
plate
plate
transfect
equal
amount
plasmid
express
spike
protein
plasmid
express
luciferas
control
promot
use
turbofect
fermenta
h
transfect
cell
plate
plate
coat
polyllysin
vero
cell
transfect
plasmid
express
polymeras
use
overlay
hek
cell
h
later
fusion
induc
proteas
treatment
min
h
induct
fusion
cell
lyse
luciferas
activ
measur
use
luciferas
assay
kit
promega
glomax
luminomet
promega
measur
light
emiss
pseudotyp
virion
assaypseudotyp
virion
produc
describ
previous
briefli
hek
cell
cotransfect
plasmid
express
sarscov
spike
protein
vector
code
mlv
gagpol
third
plasmid
code
genom
contain
luciferas
report
gene
cell
incub
h
supernat
collect
filter
filter
transduct
hek
cell
coexpress
dcsign
plate
plate
coat
polyllysin
cell
preincub
mm
nh
cl
h
inhibit
entri
endosom
pathway
transfer
ice
quantiti
pseudotyp
virion
bound
h
rpmi
medium
contain
bovin
serum
albumin
mm
hepe
mm
nh
cl
cell
warm
rpmi
medium
contain
indic
quantiti
elastas
trypsin
cell
incub
min
complet
medium
contain
mm
nh
cl
medium
replac
fresh
medium
cell
lyse
h
later
luciferas
activ
quantifi
use
luciferas
assay
kit
promega
light
emiss
measur
use
glomax
luminomet
spike
protein
cleavag
analysishek
cell
plate
polyllysineco
plate
cotransfect
plasmid
express
wild
type
mutant
spike
protein
use
turbofect
fermenta
next
day
cell
treat
h
proteas
trypsin
elastas
cell
transfer
ice
cell
surfac
protein
biotinyl
cell
incub
icecold
phosphatebuff
salin
contain
gml
sulfonhssbiotin
sulfosuccinimidyl
biotinamido
pierc
min
twice
free
biotin
quench
two
incub
min
mm
glycin
phosphatebuff
salin
cell
lyse
use
radioimmunoprecipit
assay
buffer
mm
trishcl
mm
nacl
sd
triton
deoxychol
acid
ph
includ
complet
proteas
inhibitor
mixtur
roch
appli
scienc
biotinyl
protein
affinityprecipit
streptavidinagaros
novagen
overnight
bead
wash
radioimmunoprecipit
assay
buffer
pellet
resuspend
sdspage
laemmli
sampl
load
buffer
contain
mm
dithiothreitol
protein
separ
sdspage
acrylamid
sarscov
cleavag
product
analyz
western
blot
use
antibodi
rho
nation
cell
cultur
center
minneapoli
mn
direct
tag
previous
demonstr
sarscov
infect
activ
exogen
elastas
studi
pancreat
elastas
use
sourc
proteas
addit
shown
previous
introduct
furin
site
posit
sarscov
induc
cellcel
fusion
independ
addit
exogen
proteas
ad
furin
cleavag
site
differ
posit
region
howev
addit
furin
cleavag
site
posit
result
cellcel
fusion
addit
furin
cleavag
site
posit
effect
cellcel
fusion
supplement
fig
therefor
hypothes
activ
fusion
cleavag
event
occur
vicin
region
identifi
potenti
elastas
cleavag
site
posit
within
sarscov
examin
region
possibl
consensu
cleavag
site
util
merop
peptidas
databas
id
contrast
trypsin
elastas
requir
amino
acid
nonpolar
aliphat
polar
uncharg
r
group
posit
prefer
prolin
posit
although
exact
match
optim
merop
cleavag
site
consensu
sequenc
identifi
residu
threonin
within
sequenc
lkptkrsfiedllf
possibl
residu
prolin
posit
sequenc
arg
repres
expect
site
trypsin
cleavag
llf
repres
core
residu
fusion
peptid
test
import
thr
elastasemedi
activ
sarscov
fusion
perform
sitedirect
mutagenesi
modifi
residu
threonin
aspart
acid
creat
mutant
sar
protein
show
cell
surfac
express
compar
wild
type
protein
supplement
fig
use
quantit
cellcel
fusion
assay
fusion
trigger
wild
type
sarscov
protein
show
dosedepend
activ
membran
fusion
elastas
ad
wherea
elastasemedi
fusion
essenti
abrog
mutant
fig
confirm
import
residu
thr
context
fusion
event
mediat
viru
entri
examin
wild
type
mutant
protein
incorpor
viral
pseu
doparticl
wild
type
protein
equal
incorpor
pseudoparticl
shown
wild
type
pseudovirion
infect
cell
via
endosom
rout
compar
level
rout
infect
effici
block
neutral
endosom
acidif
nh
cl
see
fig
although
cell
surfacebound
wild
type
pseudovirion
could
induc
enter
cell
treatment
entri
sever
limit
case
mutant
pseudovirion
fig
control
repeat
experi
use
trypsin
fusion
trigger
case
wild
type
mutant
pseudovirion
abl
enter
cell
effici
indic
residu
thr
critic
sarscov
entri
via
altern
proteas
trigger
util
elastas
seen
fig
elastaseinduc
infect
cell
surfac
less
effici
compar
infect
induc
trypsin
rel
low
infectioninduc
effici
could
due
natur
recognit
site
posit
shift
trypsinexpos
n
terminu
fusion
peptid
sequenc
lkptkrsfiedllf
ideal
cleavag
site
consensu
sequenc
next
mutat
threonin
alanin
creat
optim
cleavag
site
creat
mutant
identifi
elastas
cleavag
site
shift
posit
expect
cleavag
site
base
previou
studi
use
trypsin
identifi
arg
cleavag
site
also
gener
seri
alanin
mutat
vicin
use
backbon
mutant
compris
use
fusion
entri
assay
goal
examin
effect
cleavag
site
posit
rel
fusion
peptid
mutant
first
assay
cell
surfac
express
supplement
fig
mutant
except
see
express
level
wild
type
protein
use
mutant
quantit
cellcel
fusion
assay
case
mutant
appar
alanin
posit
could
use
effici
fig
case
presenc
alanin
gave
higher
level
fusion
mediat
thr
addit
maximum
fusion
reach
lowest
dose
elastas
mutant
even
though
mutant
show
lower
surfac
express
compar
wild
type
protein
supplement
fig
howev
presenc
alanin
posit
allow
elastaseinduc
fusion
mutant
gave
high
level
background
fusion
absenc
elastas
addit
presum
via
activ
endogen
proteas
could
use
cellcel
fusion
assay
design
assess
role
elastas
data
shown
next
assess
function
alanin
mutant
viral
pseudoparticl
incorpor
spike
protein
pseudotyp
virion
monitor
cell
surfac
express
viral
particl
product
partial
impair
case
eg
mutant
see
supplement
fig
ensur
equal
amount
viral
particl
use
infect
assay
adjust
volum
supernat
result
level
infect
obtain
endosom
pathway
mutant
compar
wild
type
protein
case
abl
use
mutant
elastasemedi
entri
assay
cellcel
fusion
assay
presenc
alanin
posit
gave
high
level
elastasemedi
entri
alanin
posit
allow
entri
assay
mutant
gave
high
level
activ
substanti
greater
wild
type
fig
control
repeat
experi
use
trypsin
entri
trigger
case
essenti
differ
entri
wild
type
mutant
pseudovirus
except
mutant
unabl
activ
trypsin
fig
seen
cellcel
fusion
assay
infect
mediat
elastas
achiev
lowest
dose
elastas
mutant
infect
level
obtain
compar
obtain
trypsin
treatment
wild
type
protein
next
analyz
cleavag
product
elastas
cell
surfac
biotinyl
assay
cleavag
product
correspond
cleavag
posit
observ
wild
type
protein
mutant
fig
lane
cleavag
effici
mutant
cleavag
product
also
detect
mutant
howev
band
migrat
slower
suggest
mutant
cleav
differ
posit
region
locat
junction
posit
previous
shown
mutat
arg
suffici
inhibit
trypsininduc
fusion
suggest
trypsin
abl
induc
fusion
use
basic
residu
ly
data
suggest
fusion
activ
could
modul
reposit
elastas
cleavag
site
vicin
fusion
peptid
determin
whether
find
also
appli
trypsinmedi
cleavag
gener
seri
mutant
contain
arginin
residu
posit
context
background
inhibit
endogen
cleavag
site
allow
us
focu
cleavag
posit
mutant
gener
backbon
protein
contain
furin
consensu
sequenc
boundari
cell
surfac
express
monitor
mutant
express
wild
type
level
supplement
fig
expect
cellcel
fusion
assay
pseudovirion
entri
assay
wild
type
mutant
could
activ
dosedepend
manner
treatment
trypsin
wherea
mutant
could
elastas
induct
presenc
arginin
posit
allow
membran
fusion
entri
fig
b
analyz
cleavag
sarscov
spike
protein
trypsin
wild
type
protein
cleav
mainli
junction
faint
band
correspond
cleavag
could
also
detect
longer
exposur
time
expect
introduct
furin
cleavag
site
facilit
cleavag
posit
doubl
mutat
result
appear
cleavag
product
migrat
slower
probabl
due
cleavag
anoth
posit
region
introduct
arginin
either
posit
restor
cleavag
posit
show
activ
sarscovmedi
membran
fusion
viru
entri
via
cleavag
posit
spike
protein
adjac
fusion
peptid
wherea
trypsin
activ
fusion
process
cleavag
event
cleavag
event
wild
type
sarscov
protein
lead
fusion
activ
elastas
occur
posit
data
demonstr
certain
degre
flexibl
posit
cleavag
event
activ
fusion
process
howev
efficaci
infect
induc
trypsin
gener
better
elastas
could
due
poor
recognit
cleavag
site
elastas
due
shift
cleavag
site
posit
fusion
peptid
cleavag
posit
ineffici
difficult
detect
mutant
cell
surfac
express
partial
impair
problemat
compar
extent
cleavag
differ
mutant
howev
mutat
gener
optim
cleavag
site
consider
increas
fusion
entri
induc
elastas
consequ
lack
sensibl
cleavag
assay
unabl
detect
differ
cleavag
efficaci
sar
wild
type
case
rule
effect
cleavag
posit
show
chang
precis
locat
cleavag
site
rel
fusion
peptid
modul
fusion
entri
introduct
alanin
posit
result
maximum
fusion
entri
induc
elastas
effect
seem
link
better
cleavag
protein
surprisingli
neither
trypsin
elastas
abl
activ
fusion
cleavag
site
locat
posit
suggest
inaccess
residu
protein
exclud
cleavag
posit
also
result
better
fusion
entri
locat
directli
n
terminu
fusion
peptid
canon
class
fusion
protein
influenza
ha
extern
fusion
peptid
consid
cleav
singl
posit
immedi
ntermin
fusion
peptid
wherea
influenza
viru
ha
normal
cleav
trypsinlik
enzym
sequenc
iqsrglfg
known
ha
also
effici
cleav
pseudomona
elastas
sequenc
iqsrglfg
howev
elastas
cleavag
event
truncat
critic
glycin
compris
n
terminu
fusion
peptid
render
ha
nonfunct
fusion
contrast
coronaviru
fusion
peptid
appear
compos
small
helic
loop
physic
separ
cleavag
site
organ
may
allow
possibl
modul
fusion
peptid
function
shift
rel
posit
core
fusion
peptid
residu
rel
site
cleavag
scenario
gener
consist
data
overal
possibl
fusion
activ
coronavirus
may
impact
activ
specif
proteas
posit
cleavag
rel
fusion
peptid
mutat
region
implic
chang
pathogenesi
host
rang
although
elastasemedi
activ
sarscov
consid
import
factor
sever
pneumonia
seen
sarscovinfect
patient
direct
associ
vivo
sourc
elastas
eg
neutrophil
coinfect
bacteria
demonstr
date
contrast
situat
initi
studi
neutrophil
elastas
fail
give
consist
activ
sarscov
smediat
fusion
data
shown
neutrophil
elastas
less
specif
merop
consensu
cleavag
site
compar
reason
behind
lack
activ
unclear
present
current
explor
use
elastas
produc
opportunist
bacteria
detail
defin
relev
elastas
activ
viral
pathogenesi
novel
mechan
modul
fusion
protein
function
shown
shift
cleavag
site
posit
rel
core
residu
fusion
peptid
indic
may
signific
factor
diseas
outcom
abil
coronavirus
undergo
host
rang
chang
